| 发明名称 |
NANOPARTICULATE MELOXICAM FORMULATION |
| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a nanoparticulate formulation of meloxicam, wherein the material is known as 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2-H-1,2-benzothiazine-3-carboxamide-1,1-dioxide and the nanoparticulate form is necessary for an easily bioavailable pharmaceutical formulation of meloxicam exhibiting anti-inflammatory, analgesic and antipyretic activity. <P>SOLUTION: The stable nanoparticulate meloxicam composition includes meloxicam particles or salts of the same and at least one surface stabilizer, wherein the meloxicam particles have effective average particle sizes of less than about 2,000 nm. <P>COPYRIGHT: (C)2011,JPO&INPIT |
| 申请公布号 |
JP2011042670(A) |
申请公布日期 |
2011.03.03 |
| 申请号 |
JP20100233858 |
申请日期 |
2010.10.18 |
| 申请人 |
ELAN PHARMA INTERNATL LTD |
发明人 |
COOPER EUGENE R;RYDE TUULA;PRUITT JOHN D;KLINE LAURA |
| 分类号 |
A61K31/5415;A61K9/00;A61K9/06;A61K9/10;A61K9/12;A61K9/14;A61K9/19;A61K9/20;A61K9/48;A61K47/14;A61K47/32;A61K47/34;A61P1/04;A61P1/12;A61P1/16;A61P5/24;A61P9/10;A61P9/14;A61P11/00;A61P11/02;A61P11/06;A61P11/16;A61P13/12;A61P15/00;A61P17/02;A61P17/04;A61P17/06;A61P17/16;A61P19/02;A61P19/08;A61P19/10;A61P25/00;A61P25/04;A61P27/02;A61P29/00;A61P31/12;A61P35/00;A61P37/08;A61P39/00 |
主分类号 |
A61K31/5415 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
